Innovation Support & Regulatory Consulting
Innovation Support & Regulatory Consulting
With our in-house innovation and consulting division, Summit Life Science, Inc. (SLS), AHF is proud to offer an extensive list of innovation services to support your research and product development needs. Specializing in process development, IP licensing, herbal medicine-based phytochemical screenings, ingredient evaluation and delivery enhancement.
Proprietary technologies allow us to design unique products with improved bioavailability and stability. Our SEDDS technology is a cutting-edge technology that creates highly water-soluble ingredients resulting in 3 to 5 times higher bioavailability and absorption rate.
Over 30 years of experience in FDA filings for API, OTC, NDA, DS, MF, IND, BD, ANDA, 505B2, NDI, GRAS, DMF, and EUA.
To support your product development project, we can offer contract research services including In Vitro, In Vivo, phytochemical animal studies and clinical trials. Our manufacturing facility can also accommodate small batch runs to test your new product.
Established extensive partnerships with pharmaceutical companies, renowned university pharmacy schools and medical schools throughout the United States.
To learn more about our innovation services, please visit – www.summit-life-science.com
SEDDS Technology Platform and Delivery System – Focuses on poorly water-soluble compounds to improve solubility, absorption and bioavailability. This addresses the New Chemical Entity challenge for new drugs, 505B2 drugs and has shown successful results on dietary supplements.
Lipsosomal Ingredient Enhancement Technology – Active ingredients enclosed in liposomes (tiny lip bubbles that are transported and released directly into the bloodstream for advanced bioavailability. Liposomal technology has been believed to deliver the benefits of intravenous therapy through the ease of oral consumption.
I20 Technology Platform and Drug Delivery System – Injection to Oral dosage (I20) – our unique technology platform focuses on peptide, protein and big molecule drug substance development. We have multiple success cases developing approved drugs, Phase III, Phase II and Concept approved development of drugs.
OTF Technology Platform and Drug Delivery System – Oral Thin Film (OTF) Technology Platform focuses on fast dissolve compounds, improving the solubility, absorption, PK and PD. This focuses on the Old Chemical Entity challenge in the formulation and 505B2 new drugs development.